This hypothesis is consistent with ambrosin's inhibition of EGF-induced auto-phosphorylation of the critical Y1068 residue of EGFR in bladder cancer cells and, to a lesser extent, in triple negative breast cancer cells. The gene discussed is EGFR; the disease is triple-negative breast carcinoma.